Twin Tree Management, LP Biomarin Pharmaceutical Inc Transaction History

Twin Tree Management, LP

$50 Billion
Q3 2024

A detailed history of Twin Tree Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Twin Tree Management, LP holds 6,400 shares of BMRN stock, worth $426,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,400

Previous 17,600 63.64%

Holding current value

$426,432

Previous $1.45 Million 69.01%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$74.43 - $92.22 $2.23 Million - $2.77 Million	29,986 Added 742.96%	34,022 $2.8 Million
Q1 2024 May 09, 2024	SELL	$83.81 - $99.0 $4.66 Million - $5.51 Million	-55,649 Reduced 93.24%	4,036 $352,000
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $985,677 - $1.27 Million	12,932 Added 27.66%	59,685 $5.75 Million
Q3 2023 Nov 14, 2023	BUY	$85.07 - $94.48 $3.98 Million - $4.42 Million	46,753 New	46,753 $4.14 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $2.89 Million - $3.88 Million	35,714 Added 114.07%	67,022 $6.94 Million
Q3 2022 Nov 10, 2022	BUY	$82.16 - $96.94 $948,126 - $1.12 Million	11,540 Added 58.38%	31,308 $2.65 Million
Q2 2022 Aug 11, 2022	SELL	$71.48 - $86.85 $437,028 - $531,000	-6,114 Reduced 23.62%	19,768 $1.64 Million
Q1 2022 May 11, 2022	SELL	$74.28 - $92.69 $696,226 - $868,783	-9,373 Reduced 26.59%	25,882 $2 Million
Q4 2021 Feb 10, 2022	BUY	$71.72 - $91.47 $1.69 Million - $2.15 Million	23,554 Added 201.3%	35,255 $3.12 Million
Q2 2021 Aug 12, 2021	BUY	$75.51 - $84.79 $415,833 - $466,938	5,507 Added 88.91%	11,701 $976,000
Q1 2021 May 17, 2021	SELL	$74.73 - $90.69 $2.67 Million - $3.25 Million	-35,784 Reduced 85.24%	6,194 $468,000
Q4 2020 Feb 12, 2021	BUY	$72.61 - $90.2 $1.73 Million - $2.15 Million	23,814 Added 131.11%	41,978 $3.68 Million
Q3 2020 Nov 13, 2020	SELL	$71.87 - $131.03 $2.5 Million - $4.56 Million	-34,830 Reduced 65.72%	18,164 $1.38 Million
Q2 2020 Aug 12, 2020	BUY	$79.55 - $124.22 $4.22 Million - $6.58 Million	52,994 New	52,994 $6.54 Million
Q2 2019 Aug 12, 2019	SELL	$80.35 - $93.9 $32,220 - $37,653	-401 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$84.2 - $98.62 $33,764 - $39,546	401 New	401 $36,000
Q2 2018 Aug 08, 2018	SELL	$76.01 - $99.03 $40,589 - $52,882	-534 Closed	0 $0
Q1 2018 May 09, 2018	BUY	$77.67 - $92.63 $41,475 - $49,464	534 New	534 $43,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Account

Twin Tree Management, LP Biomarin Pharmaceutical Inc Transaction History